Navigation Links
TSI Announces 2013 Respiratory Protection Roadshow Training Dates and Locations
Date:5/15/2013

SHOREVIEW, Minn., May 15, 2013 /PRNewswire/ -- TSI is pleased to announce that industry recognized instructor, Dr. Roy McKay of the University of Cincinnati, is again teaming up with TSI to offer the most comprehensive respiratory protection training in a one-day course at various locations throughout the country. Designed for all levels of experience, this expert will cover current standards regulating respiratory protection, approved fit testing methods and correct techniques to administer and maintain a successful respiratory protection program.

Proper respiratory protection is a common, increasing problem. In 2012, Respiratory Protection was cited by OSHA as #4 most cited violations and penalties, up from #5 in 2011. In an effort to advance your risk management program, and ensure your compliance with government regulations, the TSI-sponsored respirator protection workshop presents a thorough overview of OSHA Respiratory Protection Standard (20CFR 1910.134), as well as guidelines as to when respirator testing is necessary. Plus, attendees will receive valuable hands-on quantitative fit test (QNFT) training utilizing the TSI PortaCount® Respirator Fit Tester as well as qualitative fit test (QLFT) training with the TSI Qfit™ Respirator Fit Tester. Discussion on how to interpret results from each method and common mistakes in that interpretation will be included.

To see a complete listing of cities and dates available, and to register to receive more information, visit www.tsi.com/roadshow2013.

About TSI Incorporated
TSI Incorporated serves a global market by investigating, identifying and solving measurement problems. As an indust
'/>"/>

SOURCE TSI Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vasomedical Announces Financial Results for the First Quarter of 2013
2. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
3. Pharmagen Announces First Quarter 2013 Results
4. BioDrain Announces First Quarter 2013 Results
5. International Isotopes Inc. Announces First Quarter 2013 Financial Results
6. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
7. Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement
8. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
9. Heska Announces Financial Results for the First Quarter of Fiscal 2013
10. DEACOM ERP Announces MRO Module for Process and Mixed Mode Manufacturing Companies
11. Natural Alternatives International, Inc. Announces Fiscal 2013 Q3 and YTD Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SAN and NYSE: SNY ) today announced ... in people with hypercholesterolemia met their primary efficacy endpoint ... lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology ... and education markets, announced today that has been no ... disclosed or, to its knowledge, any other reason to ... "We have noticed unusual price and volume increases for ... Steve Barbee , CEO of DigiPath. "While we ...
(Date:7/30/2014)... July 30, 2014  Packaging Coordinators, Inc. (PCI) is ... to acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma ... in the United Kingdom and ... and Tokyo , Japan. Penn ... Clinical and Commercial dosage form manufacturing, as well as ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
(Date:7/30/2014)... Of the many sub-groups of cells jockeying for ... not be those that can proliferate the fastest, researchers ... in an advance online publication of the journal ... the treatment of cancer with precision medicines, the study ... are truly driving the tumor,s growth and metastasis and ...
(Date:7/30/2014)... July 30, 2014 Everyone knows that the ... basically everyone. Whether people are looking for something to buy, ... a dentist, the internet is pretty much always going to ... Dental in Lauderdale Florida is so happy to announce the ... web presence into the modern age. Whether a person wants ...
(Date:7/30/2014)... Dallas, Texas (PRWEB) July 30, 2014 ... provides key market data on the North America Contrast ... of US dollars, and volume (in units) and average ...     CT Injectors ,     Interventional Cardiology/Angio Injectors ... medium (or contrast agent) is a substance used to ...
(Date:7/30/2014)... (WAVES) conference is coming to Fairfield, Iowa,s Maharishi University ... August 3. To watch the main plenary talks, visit ... such a large and diverse group of Vedic scholars ... relevance of ancient Vedic knowledge in today,s world. Topics ... and reflections on the various Vedic texts. , The ...
(Date:7/30/2014)... Naomi Fried, PhD, and Alexis Gilroy, ... of the American Telemedicine Association (ATA). The ... a mission to promote professional, ethical and equitable ... technology. , “Both Naomi Fried and Alexis Gilroy, ... and are well known experts in their respective ...
Breaking Medicine News(10 mins):Health News:Target growth-driving cells within tumors, not fastest-proliferating cells 2Health News:Target growth-driving cells within tumors, not fastest-proliferating cells 3Health News:Sierra Dental Releases New Website For Fort Lauderdale Residents 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2
... The Justice Department,today announced that it has reached ... is headquartered in Southfield, Mich., under the,Americans with ... Weight,Loss Clinic refused to serve a prospective client ... of today,s agreement, Medical Weight Loss Clinic will,provide ...
... to announce the arrival of newly FDA-approved Evolence®--the latest injectable ... beauty treatments. EVOLENCE® utilizes highly-purified porcine Type I collagen, regarded ... identical similarity to human collagen. , ... ...
... G.,Rendell today issued an executive order regarding the ... after the law,authorizing its operation expired on June ... when PHC4 was allowed to "sunset",by the General ... The Rendell administration is committed to creating ...
... serve a distinct advantage on, the road to recovery, said Carl ... ... July 8 The Mariners Inn shelter and treatment,center in downtown Detroit is ... chief operating officer., "Both Jim and David are outstanding leaders in the ...
... Reductions in Iron Blood Levels Associated with Decreased Cancer Risk ... peripheral arterial disease who participated in a randomized controlled trial ... had a reduced incidence of cancer relative to men in ... studies have suggested that lower levels of iron in the ...
... Act yet to show drop-off in access predicted by ... patients have not lost access to care despite federal ... recent years, a new report finds. , Critics feared ... would make treatment more difficult, but investigators from the ...
Cached Medicine News:Health News:Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 2Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 3Health News:Mariners Inn Announces New Executive Leadership 2Health News:Also in the July 8 JNCI 2Health News:Also in the July 8 JNCI 3Health News:Also in the July 8 JNCI 4Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2
... Single Use reloadable linear stapler for resection, ... ,The Auto Suture™ MULTIFIRE GIA™ 60 and ... GIA™ 60 and 80 single use loading ... 60 knifeless single use surgical stapler with ...
... Loading Units With Titanium Staples ... (Single Use Reloadable Staplers With ... ILA™ 75 single-use stapler, anastomotic ... in the resection, transection, and/or ...
... The PROXIMATE HCS Procedure for Prolapse ... rows of titanium staples in 33mm diameter ... anal canal for transection and resection of ... the surgical treatment of hemorrhoidal disease. The ...
The Reusable Purse String Clamp is intended for use in the mechanical construction of a purse string suture. The clamp can be used on any part of the gastrointestinal tract except the esophagus....
Medicine Products: